PMID: 7026176Aug 1, 1981Paper

Biologic markers in cancer diagnosis and treatment

Current Problems in Cancer
E D HolyokeM S Arnott


We have reviewed several tumor markers that our advocates feel are now clinically useful, involve current assay technology, and are based on already available information. These include, in selected instances, estrogen receptors for breast cancer, thyrocalcitonin for medullary cancer of the thyroid, prostatic acid phosphatase for cancer of the prostate, alpha-fetoprotein for hepatocellular cancer, and carcinoembryonic antigen for monitoring colon cancer. We have considered the potential use of measurement of serum proteases and protein degradation products due to their activity as possible future areas of development, and we have explored measurement of tissue aryl hydrocarbon hydroxylase to identify populations at risk of cancer resulting from chemical carcinogenesis. It is clear that the study of tumor markers is already improving patient care in some specific areas and offers exciting potential for the future.


Oct 1, 1978·Australian and New Zealand Journal of Medicine·J A CuthbertJ R Turtle
May 1, 1975·The Journal of Clinical Investigation·G W SizemoreJ M Larson
Nov 6, 1976·Lancet·F M RibeiroG Milhaud
Jan 1, 1977·Annals of Surgery·M A HerreraA Mittelman
Dec 22, 1977·The New England Journal of Medicine·A G FotiR R Malvaez
Oct 1, 1977·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·S von Kleist
Jun 1, 1978·Cancer·W D BelvilleA W Bruce
May 1, 1978·Archives of Andrology·B K ChoeN R Rose
May 1, 1978·Archives of Andrology·B K ChoeN R Rose
Apr 15, 1979·International Journal of Cancer. Journal International Du Cancer·J LindgrenM Seppälä
Feb 1, 1979·Clinical Biochemistry·D E Mahan, B P Doctor
Mar 1, 1975·The Journal of Clinical Endocrinology and Metabolism·L J DeftosJ G Parthemore
Sep 1, 1975·Annals of Surgery·G E BlockT Z Polley
Jan 1, 1975·Journal of Surgical Oncology·V SahadevanH Sky-Peck
Feb 1, 1976·Scientific American·B W O'Malley, W T Schrader
Jan 1, 1976·Annals of Surgery·A SinghakowintaV K Vaitkevicius
Dec 1, 1975·Cancer Treatment Reviews·R J King
Dec 1, 1977·Cancer·M E Whitcomb, R L Parker
Jun 1, 1977·Cancer·H J Tagnon
Mar 13, 1978·JAMA : the Journal of the American Medical Association·C G MoertelV L Go
May 1, 1978·Annals of Internal Medicine·M S LoewensteinN Zamcheck
Aug 31, 1978·The New England Journal of Medicine·H J WaneboH F Oettgen
Nov 2, 1978·The New England Journal of Medicine·K GrazeS Reichlin

❮ Previous
Next ❯


Dec 1, 1989·Cancer Metastasis Reviews·J M Jessup, P Thomas
Nov 1, 1983·Veterinary Immunology and Immunopathology·S Krakowka, A L Wallace
Sep 1, 1985·Cancer Treatment Reviews·S E Bates, D L Longo
Jan 1, 1987·Biomaterials, Artificial Cells, and Artificial Organs·U R Shettigar, W J Kolff
May 8, 2015·Der Pathologe·W Saeger

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.